Search
With the 2025 national medical insurance negotiations on the horizon, the Class C catalog is poised to advance in tandem. A symposium held on June 16th unveiled that the Class C catalog will undergo a significant transformation, being rebranded as the "Innovative Pharmaceutical Products Catalog for Commercial Health Insurance" and incorporated for the first time into the national negotiation work plan, garnering considerable attention. This pivotal adjustment entails three primary shifts: a change in name, synchronization with national negotiations, and the potential withdrawal of direct participation by commercial insurance companies in catalog formulation. Pharmaceutical companies now face pressing challenges and must closely monitor subsequent policy developments, as well as the implications of these catalog adjustments on their products.
-
C114 Communication Network -
Communication Home
